Tradewinds Capital Management, LLC Gilead Sciences, Inc. Transaction History

Tradewinds Capital Management, LLC

$372 Million
Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 190 shares of GILD stock, worth $17,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190

Previous 190 -0.0%

Holding current value

$17,850

Previous $13,000 15.38%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $6,880 - $7,839	-89 Reduced 31.9%	190 $15,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $5,546 - $7,962	89 Added 46.84%	279 $0
Q2 2022 Jul 21, 2022	SELL	$57.72 - $65.01 $9,812 - $11,051	-170 Reduced 47.22%	190 $12,000
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $4,054 - $5,080	70 Added 24.14%	360 $21,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $12,976 - $14,728	-200 Reduced 40.82%	290 $21,000
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $8,885 - $9,709	140 Added 40.0%	490 $34,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $11,574 - $13,440	160 Added 84.21%	350 $27,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $2,505 - $3,208	40 Added 26.67%	190 $14,000
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $3,450 - $3,795	-56 Reduced 27.18%	150 $10,000
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $3,500 - $3,864	56 Added 37.33%	206 $13,000
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $1,750 - $1,961	-28 Reduced 15.73%	150 $10,000
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $21,189 - $27,650	-350 Reduced 66.29%	178 $11,000
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $10,977 - $12,153	-154 Reduced 22.58%	528 $41,000
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $5,193 - $6,096	-73 Reduced 9.67%	682 $49,000
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $54,443 - $64,529	755	755 $61,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Account

Tradewinds Capital Management, LLC Gilead Sciences, Inc. Transaction History